Metabolic dysfunction–associated steatohepatitis (MASH) is a progressive liver disease associated with liver-related complications and death. The efficacy and safety of tirzepatide, an agonist ...

Medical students and faculty at the University of Pittsburgh have been teaching middle-school students from marginalized racial and ethnic groups how to perform bystander CPR. From the Departments ...

In an effort to reduce racial disparities in prenatal health, a Yale-based transdisciplinary research team, clinicians, and payers developed a program to deliver prenatal care in a group format.

The Disability Ingetration Toolkit was developed at SUNY Upstate to help educators enhance medical students’ knowledge, skills, and cultural competencies regarding the care of people with ...

A 51-year-old woman presented with a 2-month history of dyspnea. A chest radiograph showed pleural effusions, and CT of the pelvis showed a pelvic mass and perihepatic ascites.

The Inclusive Dermatology Atlas from the University of New Mexico was designed to address disparities in diagnostic accuracy and thereby reduce disease burden, especially among patients of color.

A total of 293 randomly assigned participants received at least one dose of survodutide or placebo. Improvement in MASH with no worsening of fibrosis occurred in 47% of the participants in the ...

In a phase 3 trial, bulevirtide monotherapy led to a virologic response in patients with chronic hepatitis D. Pegylated interferon (peginterferon) alfa-2a is recommended by guidelines as an off ...

Hepatitis D virus (HDV) infection is the most serious form of viral hepatitis, with an accelerated clinical course and heightened risks of cirrhosis and liver cancer. 1 No therapies for HDV ...